Literature DB >> 10693934

Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1.

A Teixeira1, N Chaverot, A D Strosberg, S Cazaubon.   

Abstract

We have previously shown that the mitogenic effect of endothelin-1 (ET-1) in primary astrocytes is dependent on activation of both extracellular signal-regulated kinase (ERK)- and cytoskeleton (CSK)-dependent pathways. In this study, we evaluated the contribution of each of these pathways to the expression and activation of proteins mediating cell cycle progression. Our results suggest that ET-1-induced expression of cyclins D1 and D3 is dependent on the ERK- and CSK-dependent pathways, respectively; moreover, a decrease in the levels of the cyclin-dependent kinase inhibitor (CKI) p27 was observed as a consequence of ERK activation. Expression of both cyclins D1 and D3 together with a decrease in the p27 levels are essential for retinoblastoma protein (pRB) phosphorylation and cyclin A expression. Furthermore, the molecular events responsible for cell-cell contact inhibition of astrocyte proliferation were found to be independent of the mitogenic pathways leading to D-type cyclin expression. Cell growth arrest in confluent astrocytes was found to be correlated with increased expression of CKI p21, resulting in inhibition of D-type cyclin-associated pRB phosphorylation and cyclin A expression. Taken together, these results indicate that cyclins D1 and D3, which constitute the key mediators of the proliferative response of primary astrocytes to ET-1, are regulated by distinct signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693934     DOI: 10.1046/j.1471-4159.2000.0741034.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Involvement of nuclear factor-kappaB in endothelin-A-receptor-induced proliferation and inhibition of apoptosis.

Authors:  M Mangelus; R Galron; Z Naor; M Sokolovsky
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 2.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

3.  Endothelin-1 stimulates expression of cyclin D1 and S-phase kinase-associated protein 2 by activating the transcription factor STAT3 in cultured rat astrocytes.

Authors:  Yutaka Koyama; Satoshi Sumie; Yasutaka Nakano; Tomoya Nagao; Shiho Tokumaru; Shotaro Michinaga
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

Review 4.  Endothelin, astrocytes and glaucoma.

Authors:  Ganesh Prasanna; Raghu Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

5.  Cell type specific signalling by hematopoietic growth factors in neural cells.

Authors:  Nadiya Byts; Anatoly Samoylenko; Helge Woldt; Hannelore Ehrenreich; Anna-Leena Sirén
Journal:  Neurochem Res       Date:  2006-10-05       Impact factor: 3.996

6.  STRAP regulates c-Jun ubiquitin-mediated proteolysis and cellular proliferation.

Authors:  Jennifer Reiner; Fei Ye; Nilesh D Kashikar; Pran K Datta
Journal:  Biochem Biophys Res Commun       Date:  2011-03-21       Impact factor: 3.575

7.  Endothelin-1 regulates oligodendrocyte development.

Authors:  Ana Gadea; Adan Aguirre; Tarik F Haydar; Vittorio Gallo
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

8.  Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway.

Authors:  Ana Gadea; Sergio Schinelli; Vittorio Gallo
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

9.  HIF-1 and c-Src mediate increased glucose uptake induced by endothelin-1 and connexin43 in astrocytes.

Authors:  José Carlos Valle-Casuso; Ana González-Sánchez; José M Medina; Arantxa Tabernero
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.